Filing Flows › Balchem (BCPC) › Q2 2026 › vs Q2 2025
Balchem (BCPC) Q2 2026 vs Q2 2025 (year over year)
Balchem's revenue rose $28.5M (+11%) from $255M in Q2 2025 to $284M in Q2 2026. The biggest changes: Product Sales Revenue +$28.3M (+11%); Royalty Revenue +$208K (+49%). Gross margin 36.5% against 36.4% (+0.1 pts).
Balchem, Q2 2026: revenue $284M (+11% year over year), operating margin 20.9%, net earnings $44.6M, operating cash flow $46.7M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Gross margin | 36.5% | 36.4% | +0.1 pts |
| Operating margin | 20.9% | 20.1% | +0.7 pts |
| Net margin | 15.7% | 15.0% | +0.7 pts |
| Free cash flow margin | 12.8% | 15.9% | -3.2 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Product Sales Revenue | $283M | $255M | $28.3M | +11% |
| Royalty Revenue | $634K | $426K | $208K | +49% |
| Revenue | $284M | $255M | $28.5M | +11% |
| Gross profit | $104M | $93.1M | $10.6M | +11% |
| Cost of revenue | $180M | $162M | $18.0M | +11% |
| Operating profit | $59.2M | $51.4M | $7.8M | +15% |
| Operating expenses | $44.5M | $41.7M | $2.8M | +7% |
| Pre-tax earnings | $57.8M | $49.0M | $8.8M | +18% |
| Other expense, net | $1.4M | $2.4M | −$991K | -41% |
| Research & development | $4.5M | $4.3M | $234K | +5% |
| Sales & marketing | $21.1M | $19.3M | $1.8M | +10% |
| General & admin | $18.8M | $18.1M | $720K | +4% |
| Net earnings | $44.6M | $38.3M | $6.3M | +17% |
| Income tax | $13.2M | $10.7M | $2.4M | +23% |
| Depreciation & amortization | $12.2M | $11.4M | $817K | +7% |
| Share-based compensation | $5.9M | $5.8M | $83K | +1% |
| Working capital & other | $16.0M | $8.3M | $7.8M | +94% |
| Operating cash flow | $46.7M | $47.3M | −$541K | -1% |
| Free cash flow (company-reported) | $36.2M | $40.7M | −$4.5M | -11% |
| Capital expenditures and proceeds from the sale of assets | $10.5M | $6.6M | $3.9M | +60% |
Questions
How much did Balchem's revenue grow year over year in Q2 2026?
Balchem's revenue rose $28.5M (+11%) from $255M in Q2 2025 to $284M in Q2 2026.
What drove Balchem's revenue change in Q2 2026?
Product Sales Revenue +$28.3M (+11%); Royalty Revenue +$208K (+49%).